| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/2009 | US20090082435 Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
| 03/26/2009 | US20090082434 Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same |
| 03/26/2009 | US20090082433 Preventative treatment and remission of allergic diseases |
| 03/26/2009 | US20090082432 Deuterium-enriched ramelteon |
| 03/26/2009 | US20090082431 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| 03/26/2009 | US20090082430 Materials and Methods for Treating Coagulation Disorders |
| 03/26/2009 | US20090082429 Antimicrobial Compositions and Methods of Use |
| 03/26/2009 | US20090082428 Spiroketals |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082425 Compounds from myrothecium sp. for inhibiting the growth of cancer cells |
| 03/26/2009 | US20090082424 Small molecule antagonists of bcl-2 family proteins |
| 03/26/2009 | US20090082423 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082422 Deuterium-enriched levetiracetam |
| 03/26/2009 | US20090082421 Crystalline Form B4 of Atorvastatin Magnesium and a Process Thereof |
| 03/26/2009 | US20090082420 Deuterium-enriched vildagliptin |
| 03/26/2009 | US20090082419 Deuterium-enriched tegaserod |
| 03/26/2009 | US20090082418 Deuterium-enriched fluvastatin |
| 03/26/2009 | US20090082417 Deuterium-enriched sdx-101 |
| 03/26/2009 | US20090082416 Deuterium-enriched bendamustine |
| 03/26/2009 | US20090082415 Topical treatment of cataracts in dogs |
| 03/26/2009 | US20090082414 Deuterium-enriched viramidine |
| 03/26/2009 | US20090082413 Deuterium-enriched letrozole |
| 03/26/2009 | US20090082412 Deuterium-enriched deferasirox |
| 03/26/2009 | US20090082411 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082408 Novel heterocyclic derivatives |
| 03/26/2009 | US20090082407 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 03/26/2009 | US20090082406 Cancer Therapy |
| 03/26/2009 | US20090082405 Deuterium-enriched pioglitazone |
| 03/26/2009 | US20090082404 Benzimidazoles |
| 03/26/2009 | US20090082403 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| 03/26/2009 | US20090082402 Methods of treating genitourinary disorders using inhibitors of soluble epoxide hydrolase |
| 03/26/2009 | US20090082401 Deuterium-enriched tiagabine |
| 03/26/2009 | US20090082400 Soluble pyrone analogs methods and compositions |
| 03/26/2009 | US20090082399 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/26/2009 | US20090082398 Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| 03/26/2009 | US20090082397 anticholinergic agents such as biphenyl-2-ylcarbamic Acid 1-{2-[5-(4-Carbamoylpiperidin-1-yl)pentylcarbamoyl]ethyl}piperidin-4-yl ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma; side effect reduction |
| 03/26/2009 | US20090082396 5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists |
| 03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082394 Tetrahydroisoquinoline Derivatives to Enhance Memory Function |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082391 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082389 Pesticidal substituted piperidines |
| 03/26/2009 | US20090082388 Co-administration of pimavanserin with other agents |
| 03/26/2009 | US20090082387 Deuterium-enriched nvp-bez234 |
| 03/26/2009 | US20090082386 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 03/26/2009 | US20090082385 Deuterium-enriched desloratidine |
| 03/26/2009 | US20090082384 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/26/2009 | US20090082383 Deuterium-enriched buprenorphine |
| 03/26/2009 | US20090082382 Deuterium-enriched naltrexone |
| 03/26/2009 | US20090082381 Percutaneously Absorbable Ophthalmic Preparation |
| 03/26/2009 | US20090082380 Deuterium-enriched rosuvastatin |
| 03/26/2009 | US20090082379 Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082378 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082376 Deuterium-enriched alogliptin |
| 03/26/2009 | US20090082375 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 03/26/2009 | US20090082374 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 03/26/2009 | US20090082373 Uses of 2-[piperidinyl]methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an analgesic effect, anti-allergic effect and histamine H1 receptor antagonism effect |
| 03/26/2009 | US20090082372 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols |
| 03/26/2009 | US20090082371 Treatment of Viral Disease and Cancer With Nf-kappaB Inhibitors |
| 03/26/2009 | US20090082370 Pharmaceutical Combinations of PK Inhibitors and Other Active Agents |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082367 Triazole derivative or a salt thereof |
| 03/26/2009 | US20090082366 Hepatitis C treatment; deuterated telaprevir (VX-950) |
| 03/26/2009 | US20090082365 Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists |
| 03/26/2009 | US20090082364 Deuterium-enriched levocedtirizine |
| 03/26/2009 | US20090082363 Deuterium-enriched posaconazole |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082361 Deuterium-enriched imatinib |
| 03/26/2009 | US20090082360 Use of tyrosine kinase inhibitors for treating CNS disorders |
| 03/26/2009 | US20090082359 5-pyridinone substituted indazoles |
| 03/26/2009 | US20090082358 Vanilloid receptor ligands and their use in treatments |
| 03/26/2009 | US20090082357 Prolyl Hydroxylase Inhibitors |
| 03/26/2009 | US20090082356 Pyrazine Derivatives and Use as P13k Inhibitors |
| 03/26/2009 | US20090082354 Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof |
| 03/26/2009 | US20090082353 Treatment of epilepsy with non-imidazole alkylamines histamine h3-receptor ligands |
| 03/26/2009 | US20090082352 Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
| 03/26/2009 | US20090082350 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082349 Thiazolones for use as pi3 kinase inhibitors |
| 03/26/2009 | US20090082348 Indazole derivatives |
| 03/26/2009 | US20090082347 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors |
| 03/26/2009 | US20090082346 Substituted Pyrrolo-Pyrazole Derivatives as Kinase Inhibitors |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082344 Methods and systems for treating disease |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082342 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/26/2009 | US20090082341 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER |
| 03/26/2009 | US20090082340 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 03/26/2009 | US20090082339 Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 03/26/2009 | US20090082338 Preventive or remedy for glaucoma |
| 03/26/2009 | US20090082337 Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
| 03/26/2009 | US20090082336 mGluR1 Antagonists as Therapeutic Agents |
| 03/26/2009 | US20090082335 Deuterium-enriched oxcarbazepine |
| 03/26/2009 | US20090082334 Deuterium-enriched quetiapine |
| 03/26/2009 | US20090082333 Remedy for xanthoma |
| 03/26/2009 | US20090082332 Purine derivatives for the treatment of viral or allergic diseases and cancers |